A detailed history of Clough Capital Partners L P transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Clough Capital Partners L P holds 8,705 shares of TMDX stock, worth $661,928. This represents 0.15% of its overall portfolio holdings.

Number of Shares
8,705
Holding current value
$661,928
% of portfolio
0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$135.68 - $176.11 $1.18 Million - $1.53 Million
8,705 New
8,705 $1.37 Million
Q4 2023

Feb 14, 2024

BUY
$36.74 - $81.08 $10,507 - $23,188
286 Added 6.63%
4,599 $362,000
Q3 2023

Nov 14, 2023

BUY
$53.47 - $96.07 $230,616 - $414,349
4,313 New
4,313 $236,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.42B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Clough Capital Partners L P Portfolio

Follow Clough Capital Partners L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

News

Stay updated on Clough Capital Partners L P with notifications on news.